AdvanCell
AdvanCell is a Sydney-based radiopharmaceutical and biotechnology company. It has raised $439.4M across 3 funding rounds, most recently a $315M Series D in 2026, from investors including T. Rowe Price, Abingworth and SV Health Investors.
Key facts
Open roles at AdvanCell
- Director, Clinical-Translational Science
- Director, CMC – Precursor Development & Manufacturing
- Director, CMC – Radiopharmaceutical Process Development
- Associate Director, CMC – Analytical Development
- Associate Director, Trial Operations & Budget
- Site Head and VP, Manufacturing
- Director of Facilities
- Director of Supply Chain and Logistics
- Director of Radiochemical Separations
Browse AdvanCell roles by location: Boston, United States · Australia
Land a role at AdvanCell
publicOpen roles & company overview
Every live role, the locations AdvanCell hires across, and the company facts — all above.
membersAlerts & tailored applications
An email the day AdvanCell posts a role, a cover letter and résumé bullets tailored to each one, and one-click apply.
Get startedEmail & phone for AdvanCell are shown to signed-in members. Sign in →